Cerapedics - Exhibitor

 

Company Contact:
Andrew Barnes
abarnes@cerapedics.com

Virtual Exhibit Hall Home

ABOUT US:

Cerapedics is an advanced orthobiologics company focused on developing its proprietary i-FACTOR® Peptide Enhanced Bone Graft powered by P-15: Osteogenic Cell Binding Peptide.

Among 400+ spinal bone grafts on the market, spine surgeons can feel confident in choosing i-FACTOR Peptide Enhanced Bone Graft, which is backed by Level 1 human clinical data from an IDE study published in Spine and Neurosurgery. In this study i-FACTOR demonstrated high fusion rates and statistical superiority vs. autograft in overall clinical success.

One of only two Class III FDA-PMA approved spinal bone grafts, i-FACTOR is the leading evidence-based alternative and is powered by a first of its kind molecule called P-15: Osteogenic Cell Binding Peptide. i-FACTOR is also free of many safety risks seen with other products, such as ectopic bone formation and costs at least 30% less expensive than other drug-device combination products.

 

Documents:
i-FACTOR Technical Overview Brochure

Regulatory Pathways Pyramid

The FIRST P-15 Peptide Sell Sheet
ISASS Guidelines

Videos:

i-FACTOR 30-second Spot

i-FACTOR Manufacturing Tour Video

 

ML-0594_i-FACTOR_Story_Brochure.pdf ML-0594_i-FACTOR_Story_Brochure.pdf

ISASS BGS Recommendations.pdf